Login
Babylon Holdings Ltd logo

Babylon Holdings Ltd

ir.babylonhealth.com

No Longer Reporting

The company has not filed an annual or quarterly report since its Q1 FY2023 10-Q, filed May 10, 2023. Its latest SEC filing is a 8-K from Aug 31, 2023.

The sections below describe the company as of the FY2022 annual report.

What Did They Do?

Provides value-based care for health plan members, and sells clinical services and digital health software to healthcare providers, insurers and other organizations.

How Did They Make Money?

Health plans and other customers pay fixed per-member monthly amounts for managed care, sometimes with added payments tied to members’ health, savings and care quality. Clinical care brings fees per consultation or per-member payments plus consultation fees, while partners pay software license fees; invoices are generally paid in the month after they are issued.

FY2022 revenue

Who Were Their Customers?

Babylon's business customers are healthcare providers, insurers, governments and employers that sponsor employee memberships. It builds its sales pipeline through inbound inquiries, outbound outreach and existing customer relationships.

Did Revenues Turn Into Profits?

No. It lost $221.4M in FY2022.

Operating income, FY2022
−33% of revenue
▲ +18% (Loss) vs FY2021 (−$312.7M, −97%)
Net income, FY2022
−20% of revenue
▲ +186% (Loss) vs FY2021 (−$77.4M, −24%)

How Were They Changing?

Since the FY2022 annual report
Latest quarter: Q1 FY2023, the three months to Mar 31, 2023
Revenue
▲ +17%
vs $266.4M in Q1 FY2022
Net income
▲ +117% (Loss)
vs −$29.1M in Q1 FY2022
  • Aug 31, 2023 eMed acquired substantially all of Babylon's remaining UK assets Babylon said its remaining controlled entities were expected to be wound down; the sale provides no payment to ordinary shareholders.
  • Aug 11, 2023 Centene terminated most of its agreements with Babylon The agreements related to healthcare services for Centene members and represented 48.1% of Babylon's revenue in FY2022.
  • Aug 7, 2023 MindMaze deal halted as Babylon exited its core U.S. business Babylon pursued a sale of its UK business after the proposed transaction would not proceed.
  • Jun 28, 2023 Babylon said it would not seek to regain NYSE listing compliance It expected its shares to be suspended and then delisted from the NYSE.

Who Did They Compete With?

Competes with Agilon health, Amwell, Oak Street Health, One Medical, Teladoc, Apple, Amazon, Facebook, Verizon, Microsoft, Kroger, CVS Health, Walgreens, Walmart, Zoom Video, and Twilio

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support